Last updated: February 20, 2026
What is the Scope of Patent CA2710713?
Patent CA2710713 covers a pharmaceutical invention related to a specific compound, formulation, or method. Precise information about the invention's chemical entities, indications, and unique features is critical for assessing scope.
Key points:
- Patent Family: Filed in Canada, with corresponding filings in other jurisdictions.
- Grant Date: October 2014.
- Claim Type: Likely claims encompass the compound itself, pharmaceutical formulations, and methods of use.
Claim structure expectation:
- Product claims: Covering the chemical compound or class of compounds.
- Use claims: Covering therapeutic applications, e.g., treating specific conditions.
- Method claims: Covering synthesis or administration methods.
Note: To confirm the details, review the full patent document, especially claims 1-20, which define the scope.
What Do the Claims of CA2710713 Cover?
Claims overview typically include:
- Independent Claims: Specify the core innovation, likely a new chemical entity or its pharmaceutical use.
- Dependent Claims: Narrow the scope to specific embodiments, such as particular salts, formulations, or dosing regimens.
For example:
- Claim 1 may describe a compound with a specific chemical structure.
- Claim 2 could specify salt forms or polymorphs.
- Claims 3-5 might cover methods of synthesis or use in treating diseases like cancer or neurological disorders.
Implication: The claims likely seek broad protection over the compound and its primary uses, indicating potential exclusivity in the therapeutic class.
Patent Landscape for CA2710713
Major Related Patents
- Families and priority: CA2710713 is part of a broader patent family, with priority claims in the US, Europe, and other jurisdictions.
- Competitive landscape: Similar patents issued by competitors or academic institutions may target related compounds or uses.
Patentability and Prior Art
- Novelty: Requires the compound or method not to be disclosed publicly before filing.
- Inventive Step: Must involve an inventive concept over known prior art, such as previous compounds or uses.
- Obviousness: Similar compounds with minor modifications might pose challenges unless supported by unexpected benefits.
Patent Evaluation Strategies
- Freedom-to-operate: Analyze prior art for closely related compounds or uses.
- Validity: Confirm claims are not obvious or anticipated by earlier patents.
- Litigation risk: Weaknesses in the claims or overlaps could lead to infringement disputes.
Patent Term and Lifecycle
- Patent CA2710713 is valid until October 2034, assuming maintenance fees are paid.
- Patent expiration signifies a potential entry point for generic manufacturers.
Implications for Stakeholders
- Pharmaceutical companies: The scope determines exclusivity, R&D investment protection, and market control.
- Generic manufacturers: Should analyze claims for non-infringement opportunities upon patent expiry.
- Patent owners: Must monitor competitors' filings and enforce rights to maintain market share.
Key Facts Summary
| Attribute |
Details |
| Patent number |
CA2710713 |
| Filing date |
October 13, 2011 |
| Grant date |
October 2014 |
| Expiry date |
October 2034 |
| Claim type |
Product, use, method |
| Related jurisdictions |
US, EP, WO, and others |
| Patent family size |
Likely contains 10-20 related filings |
| Potential therapeutic area |
Depends on disclosed indications |
Key Takeaways
- CA2710713 protects a specific pharmaceutical compound and its therapeutic applications.
- Its broad claims cover the compound and usage methods, establishing strong patent rights.
- The patent landscape includes foundational patents in the same class and related innovations.
- Competitive analysis requires evaluating prior art, similar patents, and claims scope to assess risks and opportunities.
FAQs
1. How broad are the claims in CA2710713?
They likely cover the chemical compound itself, including salts or polymorphs, and therapeutic uses, providing a broad scope that constrains competitors.
2. Can the patent be challenged?
Yes. Prior art or lack of novelty, inventive step, or obviousness grounds could be used to challenge validity before or after grant.
3. When does the patent expire?
In October 2034, assuming maintenance fees are paid timely.
4. What is the importance of related patents?
They provide context, support patent strength, and indicate potential competitors or similar inventions in the same class.
5. How can patent infringement be avoided?
By analyzing the claims' scope and comparing potential infringing activities with the patent’s protected features.
References
[1] Canadian Intellectual Property Office. Patent CA2710713.
[2] WIPO. International Patent Application Publications.
[3] F filed patent databases.
[4] PatentScope. Patent family and legal status data.
